Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNRHR | P30968 | 14/20 | 0.65 |
| ▸ | FPR1 | P21462 | 1/20 | 0.65 |
| ▸ | GPR183 | P32249 | 1/20 | 0.65 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.65 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4860057 | 0.79 | GNRHR (0.66) | GNRHRFPR1GPR183GPR119S1PR4 | |
| SCHEMBL208907 | 0.79 | GNRHR (1.00) | GNRHRFPR1GPR183GPR119 | |
| SCHEMBL31060713 | 0.79 | GNRHR (1.00) | GNRHRFPR1GPR183GPR119 | |
| SCHEMBL14395921 | 0.78 | GNRHR (0.65) | GNRHRFPR1GPR183GPR119S1PR4 | |
| SCHEMBL5834658 | 0.77 | GNRHR (0.82) | GNRHRFPR1GPR183GPR119 | |
| SCHEMBL5835519 | 0.77 | GNRHR (0.63) | GNRHRFPR1GPR183GPR119S1PR4 | |
| SCHEMBL5835109 | 0.76 | GNRHR (0.81) | GNRHRFPR1GPR183GPR119 | |
| SCHEMBL5835400 | 0.76 | GNRHR (0.69) | GNRHRFPR1GPR183GPR119S1PR4 | |
| SCHEMBL5705276 | 0.75 | GNRHR (0.71) | GNRHRFPR1GPR183GPR119S1PR4 | |
| SCHEMBL5266205 | 0.75 | GNRHR (0.71) | GNRHRFPR1GPR183GPR119S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7101878-B1 | Non-peptide GNRH agents, methods and intermediates for their preparation | AGOURON PHARMACEUTICALS, INC. (US) | 2006-09-05 | — | — | US | disclosed |
| EP-1105120-B1 | NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION | AGOURON PHARMA (US) | 2005-03-23 | — | — | EP | disclosed |
| EP-1105120-A4 | NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION | AGOURON PHARMA (US) | 2001-12-19 | — | — | EP | disclosed |
| EP-1105120-A2 | NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION | AGOURON PHARMACEUTICALS, INC. (US) | 2001-06-13 | — | — | EP | disclosed |
| WO-2000020358-A2 | NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION | AGOURON PHARMACEUTICALS, INC. (US) | 2000-04-13 | — | — | WO | disclosed |